Sickle Cell Disease - Cardiovascular Update

Early sickle cell disease intervention may lower stroke risk

Medical Xpress - Cardiology

FEBRUARY 27, 2025

Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but because of its potential drawbacks and costs, patients and caregivers often face the difficult decision of whether to undergo the procedure.

Early sickle cell disease intervention may lower stroke risk

Voxelotor for Sickle Cell Disease Recalled After Safety Concerns

Sickle Cell Disease Linked to Higher Risk of Retinal Vascular Occlusion

Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

Researchers identify safety of a potential new treatment to manage complications from sickle cell disease

Safety of a potential new treatment to manage complications from sickle cell disease

Study Addresses Menstrual Pain in Sickle Cell Disease, Role of Reproductive Health Specialists

Hydroxyurea Therapy May Affect Fertility in Sickle Cell Disease

Mortality in U.S. Youth; Gene Therapy for Sickle Cell Disease

Children with Sickle Cell Disease Experience Severe COVID-19 Infection

Elna Saah, MD: Unraveling the Current Landscape in Sickle Cell Disease

Sickle Cell Disease May Play Role in Childhood Lead Poisoning Cases

Presence of CKD in Sickle Cell Disease Worsens In-Hospital Outcomes

Social Determinants of Health Impact Sickle Cell Disease Mortality in US

Allogenic HSCT May Improve Sickle Cell Disease-Related Organ Dysfunction

Study Reveals Research Gaps on Acute Pancreatitis in Sickle Cell Disease

Disease Status Influences VTE Risk in Women with Sickle Cell Disease

Updates, News in Sickle Cell Disease, with Steven Fein, MD

CDC Opioid Guidelines Linked to Negative Consequences in Sickle Cell Disease

Abnormal ECG Findings Prevalent Among People with Sickle Cell Disease

Study Reveals Higher Prevalence of STIs Among Adolescents, Young Adults with Sickle Cell Disease

Stroke rates increasing in individuals living with SCD despite treatment guidelines

Clinical Pain Screening Proves Feasible in Pediatric Sickle Cell Disease

Pain Scores, Opioid Receipt Predict Hospitalization in Children with Sickle Cell Disease

Sickle Cell Disease with Venous Thromboembolism Linked to Higher Mortality

Hearing Loss Prevalence High in Children, Adults with Sickle Cell Disease

Substance Use Disorder of Nitrous Oxide Uncommon in Sickle Cell Disease

Children with Sickle Cell Disease Show No Alarming Trends After Opioid Use

Patients with SCD Face Early Death Despite Improved Survival Rates

Emergency Department Use for Sickle Cell Declined at Onset of COVID-19

Hydroxyurea Therapy Shown Not to Impact Onset of Puberty in Male Sickle Cell Disease Patients

Hematology Month in Review: March 2024

Stroke rates increasing in individuals living with sickle cell disease despite treatment guidelines: Study

Frequent Hospitalized VOCs Worsens Mortality Risk in Sickle Cell Disease

Abstract TP147: Assessment of Inter-Rater Reliability of Fazekas Scoring on Magnetic Resonance Imaging in Patients With Sickle Cell Disease

RUBY: Reni-Cel Displays Promising Efficacy, Safety for Sickle Cell Disease

Exa-Cel Shows Long-Term Clinical Benefit in Sickle Cell Disease, TDT

Voxelotor Improves Cerebral Hemodynamic Parameters in Pediatric Sickle Cell Disease

Voxelotor Benefits Red Blood Cell Functionality in Pediatric Sickle Cell Disease

SGLT2is, GLP-1s Display Reno-Protective Benefit in Sickle Cell Disease

Age, Genetics Help Predict Proliferative Sickle Cell Retinopathy

Dexamethasone Raises VTE Risk in COVID-19 Cases with Sickle Cell

Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy

Stay Connected